Humanetics Corp. Wows at 2024 DoD Scientific Meeting: A Testimony to Enduring Innovation
Humanetics Corporation presented updates on the progress of BIO 300, an orally administered drug designed to prevent radiation toxicity...
Allele-Selective Therapies for Rare Genetic Disorders: Regulatory Challenges and Solutions
Recent advances in genetic sequencing have identified an increasing number of rare heterozygous toxic gain-of-function (TGOF) mutations. These mutations...
DeepCure Presents Breakthrough Data: DC-9476 Triumphs over Etanercept in Rheumatoid Arthritis Battle
DeepCure, a biotechnology company, has unveiled promising data on its selective BRD4 (BD2) inhibitor, DC-9476. Preclinical studies indicate its...
Calquence (Acalabrutinib) Receives Priority Review in the US for Untreated Mantle Cell Lymphoma Patients
AstraZeneca‘s CALQUENCE (acalabrutinib) has received Priority Review designation from the FDA for treating untreated adult patients with mantle cell...
How Causal Machine Learning is Transforming Clinical Trials
Welcome to an insightful discussion on the future of clinical trials and the role of causal machine learning in...
Wellvii™ and Dr. Todd McMullen: VitalDetect® for Remote Blood Pressure Patient Monitoring in Rural Areas
Wellvii’s VitalDetect offers a groundbreaking approach to non-invasive blood pressure monitoring. Unlike traditional arm cuffs, the VitalDetect utilizes a...
Unparalleled Launch: VMD Sciences Expands Life-Saving Access Programs
VMD Sciences, a pioneering company in biomedical innovation for pets, has launched Expanded Access Programs (EAPs) for pets and...
Unlock Real Chemistry’s Elevate Partnership for Exceptional Biopharma Commercialization
Real Chemistry and Corval have forged a partnership to provide biopharma companies with an innovative platform for commercialization planning...
Gilead Patents Free Access to HIV Prevention Drug for Low-Resource Countries
Gilead Sciences has granted non-exclusive, royalty-free licenses to six generic manufacturers to produce and distribute lenacapavir in 120 low-income...
Biotheus and Immunoprecise Ink Material Transfer Agreement: A Promising Collaboration for Immunotherapy Advancement
ImmunoPrecise Antibodies and Biotheus have collaborated to develop bispecific therapies for solid tumors. Biotheus will evaluate Talem Therapeutics’ AI-enhanced...